Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250-->Asn; Ser251-->Cys) resulting in lipoprotein lipase (LPL) deficiency

Neth J Med. 1996 Nov;49(5):189-95. doi: 10.1016/0300-2977(96)00043-5.

Abstract

Two missense mutations in exon 6 of the LPL gene were identified on separate alleles in a Dutch patient with lipoprotein lipase (LPL) deficiency. The first mutation is a G1003-->A transition resulting in a D250N mutation, which has been shown previously to result in a catalytically defective protein in patients of French-Canadian ancestry. The second mutation, a C to G transition at nucleotide 1007, predicts a S251C residue change in the highly conserved region of LPL surrounding the loop structure the covers the catalytic triad. This mutation constitutes a novel defect among LPL gene mutations reported so far. Site-directed mutagenesis experiments provide in-vitro evidence for the complete loss of LPL activity resulting from this latter missense mutation. The G1003-->A nucleotide substitution underlying the Asp250 mutation deletes a TaqI endonuclease recognition site and the C1007-->G change that leads to the S251C alteration abolishes a HinfI recognition site. This will facilitate rapid screening for these mutations in LPL-deficient patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Asparagine / genetics
  • Aspartic Acid / genetics
  • Cysteine / genetics
  • DNA / analysis
  • Denmark
  • Heterozygote*
  • Humans
  • Hyperlipoproteinemia Type I / genetics*
  • Hypertriglyceridemia / genetics*
  • Lipoprotein Lipase / deficiency
  • Lipoprotein Lipase / genetics*
  • Male
  • Mutagenesis, Site-Directed
  • Point Mutation*
  • Polymerase Chain Reaction
  • Serine / genetics

Substances

  • Aspartic Acid
  • Serine
  • Asparagine
  • DNA
  • Lipoprotein Lipase
  • Cysteine